Axa’s Dermira, Inc. DERM Stock Holding History

Axa’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-25,500	Closed	-$204K	–	1442
2018 Q1	$204K	Sell	25,500 -277,974	-92%	-$6.05M	﹤0.01%	1319
2017 Q4	$8.44M	Buy	303,474 +3,141	+1%	+$83.3K	0.03%	523
2017 Q3	$8.11M	Buy	300,333 +88,079	+41%	+$2.3M	0.03%	501
2017 Q2	$6.18M	Hold	212,254	–	–	0.03%	556
2017 Q1	$7.24M	Buy	212,254 +20,795	+11%	+$671K	0.03%	513
2016 Q4	$5.81M	Sell	191,459 -310	-0.2%	-$9.99K	0.03%	538
2016 Q3	$6.49M	Buy	191,769 +3,135	+2%	+$101K	0.03%	516
2016 Q2	$5.52M	Buy	188,634 +96,222	+104%	+$2.66M	0.02%	545
2016 Q1	$1.91M	Buy	+92,412	New	+$2.27M	0.01%	757

Other funds holding DERM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Axa's DERM Position: Q2 2018 in Review

Axa sold out of Dermira, Inc. (DERM) in Q2 2018, closing a stake of 25,500 shares — an estimated $204K sold.

Axa first reported a position in DERM in Q1 2016 and held it in 9 quarters. The position peaked at $8.44M in Q4 2017. 119 funds tracked by Wall St. Rank hold DERM as of Q2 2018.

Axa reported no remaining Dermira, Inc. position as of Q2 2018 after selling out during the quarter.
Axa sold 25,500 Dermira, Inc. shares in Q2 2018, an estimated $204K.
Axa first reported a position in Dermira, Inc. in Q1 2016 and held it in 9 quarters.
Axa's Dermira, Inc. position peaked at $8.44M in Q4 2017.
119 funds tracked by Wall St. Rank held Dermira, Inc. as of Q2 2018.

Based on Axa's 13F filing for Q2 2018, filed 13 Aug 2018.